Search Results

MN-64 50 mg  | Purity Not Available

TargetMol

MN-64 is a tankyrases inhibitor, showed 6 nM potency against tankyrase 1, isoenzyme selectivity, and Wnt signaling inhibition.

More Information Supplier Page

MN-64 10 mg  | Purity Not Available

TargetMol

MN-64 is a tankyrases inhibitor, showed 6 nM potency against tankyrase 1, isoenzyme selectivity, and Wnt signaling inhibition.

More Information Supplier Page

MN-64 100 mg  | Purity Not Available

TargetMol

MN-64 is a tankyrases inhibitor, showed 6 nM potency against tankyrase 1, isoenzyme selectivity, and Wnt signaling inhibition.

More Information Supplier Page

SC66 5 mg  | 99.60%

TargetMol

SC66 is a AKT inhibitor in HepG2, HA22T/VGH, and PLC/PRF/5 cells (IC50: about 0.75 μg/ml, at 72 h).

More Information Supplier Page

Eslicarbazepine Acetate 50 mg  | 100.00%

TargetMol

Eslicarbazepine Acetate (Zebinix) is an anticonvulsant medication approved for use in Europe, the United States and Canada as an adjunctive therapy for partial-onset seizures that are not adequately controlled with conventional therapy.

More Information Supplier Page

Eslicarbazepine Acetate 500 mg  | 100.00%

TargetMol

Eslicarbazepine Acetate (Zebinix) is an anticonvulsant medication approved for use in Europe, the United States and Canada as an adjunctive therapy for partial-onset seizures that are not adequately controlled with conventional therapy.

More Information Supplier Page

Eslicarbazepine Acetate 10 mg  | 100.00%

TargetMol

Eslicarbazepine Acetate (Zebinix) is an anticonvulsant medication approved for use in Europe, the United States and Canada as an adjunctive therapy for partial-onset seizures that are not adequately controlled with conventional therapy.

More Information Supplier Page

Eslicarbazepine Acetate 100 mg  | 100.00%

TargetMol

Eslicarbazepine Acetate (Zebinix) is an anticonvulsant medication approved for use in Europe, the United States and Canada as an adjunctive therapy for partial-onset seizures that are not adequately controlled with conventional therapy.

More Information Supplier Page